๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Thymidylate synthase: A target for anticancer drug design

โœ Scribed by K.R. Harrap; A.L. Jackman; D.R. Newell; G.A. Taylor; L.R. Hughes; A.H. Calvert

Book ID
118372132
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
933 KB
Volume
29
Category
Article
ISSN
0065-2571

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Farnesyltransferase as a target for anti
Farnesyltransferase as a target for anticancer drug design
โœ Yimin Qian; Saรฏd M. Sebti; Andrew D. Hamilton ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 233 KB ๐Ÿ‘ 2 views

The currently understood function for Ras in signal transduction is in mediating the transmission of signals from external growth factors to the cell nucleus. Mutated forms of this GTP-binding protein are found in 30% of human cancers with particularly high prevalence in colon and pancreatic carcino

Thymidylate synthase inhibition: A struc
Thymidylate synthase inhibition: A structure-based rationale for drug design
โœ M. Paola Costi ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 432 KB ๐Ÿ‘ 2 views

Thymidylate synthase (TS) is a very interesting target in antiproliferative diseases. Its inhibition causes thimineless death of the cells and compounds inhibiting TS are widely used in anticancer therapy. The classical antifolate TS inhibitors are structural analogs of the folate cofactor; they oft